Cachet(SZ:002462) Zhong Guo Ji Jin Bao·2026-01-27 14:57Core Viewpoint - The announcement from Jia Shitang indicates a potential change in its controlling shareholder and actual controller, leading to a temporary suspension of trading for up to two trading days starting January 28 [1][3]. Group 1: Company Overview - Jia Shitang is a major platform for China Everbright Group in the health sector, with its stock price at 16.40 CNY per share and a total market capitalization of 4.784 billion CNY as of January 27 [1][5]. - The major shareholders of Jia Shitang are China Everbright Medical Health Industry Co., Ltd. and China Everbright Industrial Group Co., Ltd., holding 14.36% and 14.12% of shares respectively [3][4]. Group 2: Financial Performance - Jia Shitang has experienced a continuous decline in performance, with net profits for the years 2022, 2023, and 2024 reported at 297 million CNY, 250 million CNY, and 161 million CNY respectively [8]. - The company's revenue for 2024 was approximately 24.02 billion CNY, a decrease of 19.93% from 2023, while net profit attributable to shareholders dropped by 35.75% to about 160.67 million CNY [10]. - For the first three quarters of 2025, the net profit attributable to shareholders decreased by 38.81% to 141 million CNY, with a significant drop in non-recurring profit as well [11].